PRESS RELEASE published on 07/09/2025 at 17:45, 9 months 23 days ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Median Technologies reports half-year liquidity contract details with TP ICAP. 60,808 shares and €58,893.66 cash as of June 30, 2025. 469 buy and 395 sell transactions in the first half of 2025 Liquidity Contract Transactions Shares TP ICAP Median Technologies
BRIEF published on 05/16/2025 at 17:50, 11 months 16 days ago Median Technologies Announces Voting Rights and Share Capital Details Share Capital Voting Rights Treasury Shares AMF Regulations Median Technologies
PRESS RELEASE published on 05/16/2025 at 17:45, 11 months 16 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights and shares as of April 30, 2025, in compliance with regulations. The French company utilizes AI for cancer diagnosis and treatment Voting Rights Shares AI Median Technologies Cancer Diagnosis
BRIEF published on 03/14/2025 at 17:50, 1 year 1 month ago Median Technologies Maintains its Eligibility for the PEA-PME Scheme PEA-PME Euronext Growth Tax Benefits Eligibility Median Technologies
BRIEF published on 02/24/2025 at 17:50, 1 year 2 months ago Median Technologies: Presentation of eyonis™ LCS at ECR 2025 Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS ECR 2025
BRIEF published on 01/31/2025 at 08:05, 1 year 3 months ago Median Technologies unveils its 2024 financial results and its 2025 outlook Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
PRESS RELEASE published on 01/31/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth
BRIEF published on 01/24/2025 at 08:05, 1 year 3 months ago Median Technologies Secures Up to €47.5 Million for AI Lung Cancer Diagnostics European Investment Bank Median Technologies AI Lung Cancer Diagnostics Eyonis™ EU And US Commercialization
PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025 AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
BRIEF published on 11/26/2024 at 17:50, 1 year 5 months ago Median Technologies Showcases AI Lung Cancer Diagnostic at RSNA 2024 Clinical Trials Eyonis™ LCS RSNA 2024 AI-powered Diagnostics Lung Cancer Screening
Published on 05/02/2026 at 00:00, 39 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 39 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.
Published on 05/01/2026 at 19:23, 5 hours 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 6 hours 54 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 7 hours 18 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 4 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 5 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 5 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 6 hours ago Minutes of the Combined General Meeting held on April 30, 2026